MEF2A
Summary: The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
myocyte enhancer factor 2A | MIM:600660 | Ensembl:ENSG00000068305 | HGNC:HGNC:6993 | PA30731 | 15q26.3 |
GO terms in MEF2A
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IDA | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding |
MF | IBA | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | ISM | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | NAS | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | IBA | GO:0001077 | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0001077 | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IPI | GO:0001085 | RNA polymerase II transcription factor binding |
MF | IBA | GO:0001102 | RNA polymerase II activating transcription factor binding |
MF | IBA | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding |
MF | IDA | GO:0003682 | chromatin binding |
MF | IDA | GO:0003700 | DNA-binding transcription factor activity |
MF | IEA | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
MF | IDA | GO:0003713 | transcription coactivator activity |
MF | IPI | GO:0005515 | protein binding |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0019901 | protein kinase binding |
MF | IPI | GO:0033613 | activating transcription factor binding |
MF | IPI | GO:0035035 | histone acetyltransferase binding |
MF | IBA | GO:0042826 | histone deacetylase binding |
MF | IPI | GO:0042826 | histone deacetylase binding |
MF | IDA | GO:0043565 | sequence-specific DNA binding |
MF | IPI | GO:0046332 | SMAD binding |
MF | IPI | GO:0046982 | protein heterodimerization activity |
CC | IBA | GO:0000790 | nuclear chromatin |
CC | ISS | GO:0000790 | nuclear chromatin |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005654 | nucleoplasm |
CC | TAS | GO:0005654 | nucleoplasm |
CC | IDA | GO:0005667 | transcription factor complex |
CC | IDA | GO:0005829 | cytosol |
BP | ISS | GO:0000002 | mitochondrial genome maintenance |
BP | IDA | GO:0000122 | negative regulation of transcription by RNA polymerase II |
BP | IDA | GO:0000165 | MAPK cascade |
BP | IDA | GO:0006351 | transcription, DNA-templated |
BP | IEA | GO:0006366 | transcription by RNA polymerase II |
BP | IEA | GO:0006915 | apoptotic process |
BP | IEP | GO:0007507 | heart development |
BP | NAS | GO:0007517 | muscle organ development |
BP | IDA | GO:0010613 | positive regulation of cardiac muscle hypertrophy |
BP | IGI | GO:0010613 | positive regulation of cardiac muscle hypertrophy |
BP | IDA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IEA | GO:0046326 | positive regulation of glucose import |
BP | ISS | GO:0048311 | mitochondrion distribution |
BP | ISS | GO:0048813 | dendrite morphogenesis |
BP | TAS | GO:0051149 | positive regulation of muscle cell differentiation |
BP | ISS | GO:0055005 | ventricular cardiac myofibril assembly |
BP | ISS | GO:0061337 | cardiac conduction |
BP | IMP | GO:0070375 | ERK5 cascade |
BP | IDA | GO:0071277 | cellular response to calcium ion |
Gene expression in normal tissue: MEF2A
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in MEF2A
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP1541 | Energy Metabolism |
wikipathways | WP1991 | SRF and miRs in Smooth Muscle Differentiation and Proliferation |
wikipathways | WP2012 | miRs in Muscle Cell Differentiation |
wikipathways | WP2023 | Cell Differentiation - Index expanded |
wikipathways | WP2029 | Cell Differentiation - Index |
wikipathways | WP236 | Adipogenesis |
wikipathways | WP2380 | Brain-Derived Neurotrophic Factor (BDNF) signaling pathway |
wikipathways | WP2795 | Cardiac Hypertrophic Response |
wikipathways | WP366 | TGF-beta Signaling Pathway |
wikipathways | WP437 | EGF-EGFR Signaling Pathway |
kegg | hsa04022 | cGMP-PKG signaling pathway - Homo sapiens (human) |
kegg | hsa04371 | Apelin signaling pathway - Homo sapiens (human) |
kegg | hsa05418 | Fluid shear stress and atherosclerosis - Homo sapiens (human) |
pid | p38alphabetadownstreampathway | Signaling mediated by p38-alpha and p38-beta |
biocarta | at1rpathway | angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling |
biocarta | erk5pathway | role of erk5 in neuronal survival pathway |
biocarta | hdacpathway | control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk) |
biocarta | mapkpathway | mapkinase signaling pathway |
biocarta | mitrpathway | signal dependent regulation of myogenesis by corepressor mitr |
biocarta | p38mapkpathway | p38 mapk signaling pathway |
biocarta | pgc1apathway | regulation of pgc-1a |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade |
reactome | R-HSA-166058 | MyD88:Mal cascade initiated on plasma membrane |
reactome | R-HSA-166166 | MyD88-independent TLR4 cascade |
reactome | R-HSA-166520 | Signaling by NTRKs |
reactome | R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade |
reactome | R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade |
reactome | R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade |
reactome | R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade |
reactome | R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade |
reactome | R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade |
reactome | R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade |
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-168898 | Toll-Like Receptors Cascades |
reactome | R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade |
reactome | R-HSA-187037 | Signaling by NTRK1 (TRKA) |
reactome | R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) |
reactome | R-HSA-198753 | ERK/MAPK targets |
reactome | R-HSA-375170 | CDO in myogenesis |
reactome | R-HSA-448424 | Interleukin-17 signaling |
reactome | R-HSA-449147 | Signaling by Interleukins |
reactome | R-HSA-450282 | MAPK targets/ Nuclear events mediated by MAP kinases |
reactome | R-HSA-450294 | MAP kinase activation |
reactome | R-HSA-525793 | Myogenesis |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
reactome | R-HSA-937061 | TRIF(TICAM1)-mediated TLR4 signaling |
reactome | R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
reactome | R-HSA-975155 | MyD88 dependent cascade initiated on endosome |
reactome | R-HSA-975871 | MyD88 cascade initiated on plasma membrane |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD105 | Triptolide | 3 |
iGMDRD289 | Parthenolide | 6 |
iGMDRD5 | Tyrphostin AG 1478 | 6 |
iGMDRD121 | GMX1778 | 3 |
iGMDRD271 | Brefeldin A | 3 |
iGMDRD202 | Curcumin | 6 |
iGMDRD137 | Indisulam | 3 |
iGMDRD263 | AACOCF3 | 3 |
iGMDRD329 | Merck60 | 2 |
iGMDRD414 | MST-312 | 3 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
iGMDRD584 | VER 155008 | 2 |
iGMDRD48 | Dexamethasone | 2 |
iGMDRD486 | Tosedostat | 3 |
iGMDRD945 | ML214 | 2 |
iGMDRD901 | ELCPK | 2 |
iGMDRD314 | Tanespimycin | 2 |
iGMDRD698 | Neratinib | 3 |
iGMDRD237 | ABT-751 | 3 |
iGMDRD52 | Rotenone | 3 |
iGMDRD255 | SB225002 | 6 |
iGMDRD138 | PX 12 | 3 |
iGMDRD356 | PNU-74654 | 2 |
iGMDRD451 | Serdemetan | 4 |
iGMDRD780 | PP-30 | 2 |
iGMDRD100 | Zebularine | 2 |
iGMDRD188 | Piperlongumine | 3 |
iGMDRD387 | CHIR-99021 | 2 |
iGMDRD889 | Compound 7d-cis | 2 |
iGMDRD126 | Tipifarnib | 2 |
iGMDRD61 | Kinetin riboside | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in MEF2A